AR095332A1 - Composiciones nutricionales que contienen un componente peptídico con propiedades anti-inflamatorias y método para reducir una respuesta inflamatoria - Google Patents
Composiciones nutricionales que contienen un componente peptídico con propiedades anti-inflamatorias y método para reducir una respuesta inflamatoriaInfo
- Publication number
- AR095332A1 AR095332A1 ARP140101035A ARP140101035A AR095332A1 AR 095332 A1 AR095332 A1 AR 095332A1 AR P140101035 A ARP140101035 A AR P140101035A AR P140101035 A ARP140101035 A AR P140101035A AR 095332 A1 AR095332 A1 AR 095332A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- nutritional compositions
- inflammatory
- peptide component
- reduce
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 230000028709 inflammatory response Effects 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 102000013691 Interleukin-17 Human genes 0.000 abstract 1
- 108050003558 Interleukin-17 Proteins 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
- -1 that is Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a composiciones nutricionales que comprenden una fuente equivalente de proteína, en donde 20% a 80% de la fuente equivalente de proteína incluye un componente peptídico que comprende SEC ID Nº 4, SEC ID Nº 13, SEC ID Nº 17, SEC ID Nº 21, SEC ID Nº 24, SEC ID Nº 30, SEC ID Nº 31, SEC ID Nº 32, SEC ID Nº 51, SEC ID Nº 57, SEC ID Nº 60, y SEC ID Nº 63, y 20% a 80% de la fuente equivalente de proteína comprende una proteína intacta, una proteína parcialmente hidrolizada, o combinaciones de las mismas. La presente además se refiere a métodos para reducir la respuesta inflamatoria y/o producción de citoquinas pro-inflamatorias, es decir, la Interleucina-17, proveyendo dichas composiciones nutricionales a un sujeto destinatario.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/833,094 US8889633B2 (en) | 2013-03-15 | 2013-03-15 | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095332A1 true AR095332A1 (es) | 2015-10-07 |
Family
ID=50483515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140101035A AR095332A1 (es) | 2013-03-15 | 2014-03-14 | Composiciones nutricionales que contienen un componente peptídico con propiedades anti-inflamatorias y método para reducir una respuesta inflamatoria |
Country Status (18)
Country | Link |
---|---|
US (2) | US8889633B2 (es) |
EP (1) | EP2983531B1 (es) |
CN (1) | CN105072928B (es) |
AR (1) | AR095332A1 (es) |
AU (1) | AU2014237014B2 (es) |
BR (1) | BR112015018335A2 (es) |
CA (1) | CA2905799C (es) |
ES (1) | ES2736313T3 (es) |
HK (1) | HK1216976A1 (es) |
MX (1) | MX365415B (es) |
MY (1) | MY172218A (es) |
NZ (1) | NZ710020A (es) |
PE (1) | PE20151978A1 (es) |
PH (1) | PH12015502071A1 (es) |
RU (1) | RU2015140269A (es) |
SG (1) | SG11201505689PA (es) |
TW (1) | TW201521603A (es) |
WO (1) | WO2014150558A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10251928B2 (en) | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
US20170020950A1 (en) * | 2015-07-23 | 2017-01-26 | Mead Johnson Nutrition Company | Methods for modulating kinases |
CN108347985A (zh) * | 2015-11-09 | 2018-07-31 | Mjn 美国控股有限责任公司 | 包含丁酸的营养组合物及其用途 |
US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
WO2017117121A1 (en) | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
RU2659240C2 (ru) * | 2016-05-23 | 2018-06-29 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) | Способ получения функционального продукта питания для реабилитации онкологических больных |
US11633486B2 (en) | 2017-04-17 | 2023-04-25 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
WO2020168439A1 (en) | 2019-02-22 | 2020-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
GB2608587A (en) * | 2021-06-25 | 2023-01-11 | Mjn Us Holdings Llc | Use of extensively hydrolysed protein |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2064092C2 (de) | 1970-12-28 | 1983-06-01 | Bayer Ag, 5090 Leverkusen | Inhibitoren für Glykosidhydrolasen aus Actinomyceten |
US3937817A (en) | 1973-02-28 | 1976-02-10 | Bayer Aktiengesellschaft | Pharmaceutical compositions containing a saccharase inhibitor |
US4016260A (en) | 1974-07-22 | 1977-04-05 | Toyama Chemical Co., Ltd. | Novel polypeptide produced by pseudomonas |
FR2474829B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
FR2474828B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application |
US4491589A (en) | 1982-05-17 | 1985-01-01 | The Trustees Of Columbia University In The City Of New York | Amino acid solutions for parenteral nutrition and methods of formulation and use |
DK589785A (da) | 1985-12-18 | 1987-06-19 | Samuelsson Ernst Gunnar | Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet |
IT1190349B (it) | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle |
FR2608050B1 (fr) | 1986-12-15 | 1990-04-13 | Bellon Labor Sa Roger | Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique |
US5230902A (en) | 1988-04-29 | 1993-07-27 | Immunotec Research Corporation | Undenatured whey protein concentrate to improve active systemic humoral immune response |
US5102871A (en) | 1989-04-24 | 1992-04-07 | Kyowa Hakko Kogyo Co., Ltd. | Nutrient composition |
FI904074A0 (fi) | 1989-08-28 | 1990-08-17 | Milupa Ag | Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk. |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
PH30997A (en) | 1990-03-12 | 1997-12-23 | Ciba Geigy | Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes. |
CA2101274C (en) | 1991-01-24 | 1998-12-15 | David J. Kyle | Microbial oil mixtures and uses thereof |
US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
GB9310472D0 (en) | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
GB9312369D0 (en) | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
US5405637A (en) | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
US5723446A (en) | 1993-12-23 | 1998-03-03 | Nestec Ltd. | Enteral formulation designed for optimized nutrient absorption and wound healing |
US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
US5605893A (en) | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
US6451368B1 (en) | 1994-04-11 | 2002-09-17 | New Zealand Dairy Board | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
US5643880A (en) | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
US5821217A (en) | 1995-10-27 | 1998-10-13 | Beth Israel Deaconess Medical Center, Inc. | Enteral formulation: low in fat and containing protein hydrolysates |
IT1277964B1 (it) | 1995-12-27 | 1997-11-12 | Biosistema Di Pier Luigi Spara | Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso |
KR100194074B1 (ko) | 1996-02-21 | 1999-06-15 | 박종헌 | 글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제 |
JP2000515139A (ja) | 1996-07-17 | 2000-11-14 | ニュートラコープ・サイエンティフィック・インク | 食欲の抑制 |
KR100221124B1 (ko) | 1996-09-23 | 1999-10-01 | 한상기 | 신규한 카제인 및 그 제조방법 |
NL1005037C2 (nl) | 1997-01-17 | 1998-07-20 | Nl Zuivelonderzoek Inst | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
CA2340223A1 (en) | 1998-08-12 | 2000-02-24 | Morinaga Milk Industry Co., Ltd. | Nutritional compositions for preventing or treating hyperlipoproteinemia |
US6077558A (en) | 1998-12-23 | 2000-06-20 | Bristol-Myers Squibb Company | Elemental nutritional products |
US6905702B1 (en) | 1999-11-08 | 2005-06-14 | Children's Hospital Los Angeles | Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
EP1112693B1 (en) | 1999-12-30 | 2006-03-22 | Kerry Group Services Ltd | Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption |
NL1014380C2 (nl) | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Darmwandversterkend voedingsmiddel. |
US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
US7666996B2 (en) | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
TWI268138B (en) | 2000-05-11 | 2006-12-11 | Kanebo Seiyaku Ltd | Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same |
KR20070069221A (ko) | 2000-06-28 | 2007-07-02 | 후지 니혼 세이토 코퍼레이션 | 신규한 이눌린 합성효소 및 이를 이용하는 이눌린의제조방법 |
GB0016189D0 (en) | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
WO2002019832A1 (en) | 2000-09-08 | 2002-03-14 | New Zealand Dairy Board | MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS |
AU1142001A (en) | 2000-10-19 | 2002-04-29 | Dsm N.V. | Protein hydrolysates |
WO2003005836A2 (en) | 2001-07-10 | 2003-01-23 | Trustees Of Boston University | Modified-fat nutritional products useful for preventing or treating obesity |
CN1231137C (zh) | 2001-07-18 | 2005-12-14 | Dsmip资产有限公司 | 乳类蛋白质水解的方法 |
DE10149668A1 (de) | 2001-10-09 | 2003-04-10 | Numico Res B V | Insulinmimetische Aminosäuresequenzen |
JP2003137804A (ja) | 2001-10-31 | 2003-05-14 | Morinaga Milk Ind Co Ltd | インターロイキン−18誘導剤 |
KR100615844B1 (ko) | 2001-11-21 | 2006-08-25 | 모리나가 뉴교 가부시키가이샤 | 안지오텐신 변환효소 저해작용을 갖는 신규 펩타이드 |
EP1359157A1 (en) | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Metallo-proteinase inhibitory agent |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
AU2003236689A1 (en) | 2002-06-04 | 2003-12-19 | Dsm Ip Assets B.V. | Protein hydrolysate rich in tripeptides |
FR2841473B1 (fr) | 2002-06-27 | 2004-09-17 | Ingredia | Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires |
AU2003264256A1 (en) | 2002-09-04 | 2004-03-29 | Dsm Ip Assets B.V. | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
TWI317636B (en) | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
KR20050044758A (ko) | 2002-11-29 | 2005-05-12 | 모리나가 뉴교 가부시키가이샤 | 시스테인 프로테아제 억제제 |
EP2141235B1 (en) | 2002-12-29 | 2014-06-11 | Toudai Tlo, Ltd. | Adiponectin receptor and gene coding for the same |
CA2523410A1 (en) | 2003-05-05 | 2004-11-18 | Unilever Plc | Hydrolysed casein product comprising tripeptides ipp and/or vpp |
DK1663298T3 (da) | 2003-09-23 | 2019-10-14 | Dsm Ip Assets Bv | Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner |
CN101987107A (zh) | 2003-10-24 | 2011-03-23 | 努特里奇亚有限公司 | 免疫调节性寡糖 |
BE1015863A6 (nl) | 2004-01-19 | 2005-10-04 | Huybrechts Lucas | Anticariogene proteinen & peptiden & sacchariden. |
CA2595520A1 (en) | 2004-01-28 | 2005-08-11 | Develogen Israel Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
EP1568707A1 (en) | 2004-02-26 | 2005-08-31 | Puleva Biotech, S.A. | Antihypertensive peptides from casein hydrolysates |
US20070203060A1 (en) * | 2004-03-01 | 2007-08-30 | Zvi Sidelman | Casein Derived Peptides And Therapeutic Uses Thereof |
KR20070034528A (ko) | 2004-05-27 | 2007-03-28 | 캄피나 네덜란드 홀딩 베.붸. | Dpp-iv 매개 질병의 예방 및/또는 치료용 의약품제조를 위한 단백질 가수분해물의 용도 |
DE102004040452A1 (de) | 2004-08-20 | 2006-02-23 | N.V. Nutricia | Peptidgemisch |
KR100560127B1 (ko) | 2004-09-04 | 2006-03-13 | 한국기초과학지원연구원 | 인산화 단백질 분석용 겔-내 표지화 및 겔-내 단리 방법및 이를 이용한 단백질의 인산화 위치 동정 방법 |
AU2005302852B2 (en) | 2004-11-12 | 2011-06-02 | N.V. Nutricia | Food composition comprising a protein-and a lipid fraction for rapidly attenuating inflammatory responses |
ES2381118T3 (es) | 2004-12-23 | 2012-05-23 | Campina Nederland Holding B.V. | Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso |
CN101106914B (zh) | 2005-01-18 | 2012-12-26 | 帝斯曼知识产权资产管理有限公司 | 营养药物性组合物 |
ES2337495T3 (es) | 2005-02-03 | 2010-04-26 | Dsm Ip Assets B.V. | Composiciones que comprenden galato de epigalocatecina e hidrolizado de proteina. |
ES2321650T3 (es) | 2005-02-09 | 2009-06-09 | Unilever N.V. | Productos alimenticios que comprenden solidos lacteos hidrolizados con sabor mejorado. |
EP1874140B1 (en) | 2005-04-28 | 2011-02-09 | Unilever N.V. | Peptides having a health benefit and compositions comprising them |
CN101171025A (zh) | 2005-04-28 | 2008-04-30 | 帝斯曼知识产权资产管理有限公司 | 新颖的营养药物性组合物 |
US20090074893A1 (en) | 2005-04-29 | 2009-03-19 | Campina Nederland Holding B.V. | Antiviral peptides |
US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
ES2319475B1 (es) | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
CN102894371A (zh) | 2005-07-01 | 2013-01-30 | 努特里希亚公司 | 含水解的蛋白质的婴儿营养品 |
GB0523806D0 (en) | 2005-11-23 | 2006-01-04 | Micromass Ltd | Mass spectrometer |
US8431531B2 (en) | 2005-11-30 | 2013-04-30 | Campina Nederland Holding B.V. | Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same |
WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
DK1800675T3 (da) | 2005-12-23 | 2011-09-05 | Nutricia Nv | Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens |
US20100167979A1 (en) | 2006-02-09 | 2010-07-01 | Calpis Co. Ltd | Rheumatoid arthritis-preventive agent for oral intake |
EP2007792A2 (en) | 2006-03-22 | 2008-12-31 | DSMIP Assets B.V. | Cholesterol lowering protein hydrolysates |
EA200802128A1 (ru) | 2006-04-12 | 2009-04-28 | ДСМ АйПи АССЕТС Б.В. | Новые нутрицевтические композиции |
CA2649842C (en) | 2006-04-21 | 2015-02-17 | Meiji Seika Kaisha, Ltd. | Composition containing peptide as active ingredient |
EP2017283A4 (en) | 2006-04-28 | 2015-12-30 | Megmilk Snow Brand Co Ltd | Peptides |
KR20080003637A (ko) | 2006-07-03 | 2008-01-08 | 한상기 | 다이어트효과가 우수한 기능성 유산균발효조성물 |
AU2007280272A1 (en) | 2006-08-04 | 2008-02-07 | Shs International Ltd | Protein free formula |
JP5493189B2 (ja) | 2006-08-09 | 2014-05-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | カゼイン複合体 |
NL1032840C2 (nl) | 2006-11-09 | 2008-05-13 | Friesland Brands Bv | Probiotische hydrolysaatvoeding voor kinderen. |
NL1033521C2 (nl) | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Kindervoedingen met geoptimaliseerde aminozuursamenstelling. |
BRPI0811857A2 (pt) | 2007-05-14 | 2014-10-21 | Biogen Idec Inc | Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados. |
US8652508B2 (en) | 2007-05-25 | 2014-02-18 | Children's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
WO2008153429A2 (en) | 2007-06-11 | 2008-12-18 | Uniwersytet Jagiellonski | A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use |
WO2009046843A1 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Therapeutic uses of peptides kvlpvpq and/or tdvngdgrhdl |
EP2230300A4 (en) | 2007-10-24 | 2012-08-08 | Otsuka Chemical Holdings Co Ltd | POLYPEPTIDE WITH IMPROVED EFFECTOR FUNCTION |
US8859210B2 (en) | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
JP5735734B2 (ja) | 2009-04-16 | 2015-06-17 | 雪印メグミルク株式会社 | 脂質代謝改善剤 |
EP2253324A1 (en) | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
EP2295535A1 (en) | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
ES2524067T3 (es) | 2009-12-04 | 2014-12-03 | Mjn U.S. Holdings Llc | Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia |
NZ601141A (en) | 2010-01-19 | 2014-07-25 | Abbott Lab | Nutritional formulas containing synbiotics |
US20120322726A1 (en) | 2010-02-24 | 2012-12-20 | Morinaga Milk Industry Co., Ltd. | Therapeutic agent for eating disorders |
EP2514435A1 (en) | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
WO2013148325A1 (en) * | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Nutritive fragments, proteins and methods |
-
2013
- 2013-03-15 US US13/833,094 patent/US8889633B2/en active Active
-
2014
- 2014-03-11 NZ NZ710020A patent/NZ710020A/en not_active IP Right Cessation
- 2014-03-11 CA CA2905799A patent/CA2905799C/en not_active Expired - Fee Related
- 2014-03-11 MY MYPI2015702455A patent/MY172218A/en unknown
- 2014-03-11 EP EP14717284.5A patent/EP2983531B1/en active Active
- 2014-03-11 AU AU2014237014A patent/AU2014237014B2/en active Active
- 2014-03-11 PE PE2015001979A patent/PE20151978A1/es not_active Application Discontinuation
- 2014-03-11 WO PCT/US2014/023608 patent/WO2014150558A1/en active Application Filing
- 2014-03-11 MX MX2015011934A patent/MX365415B/es active IP Right Grant
- 2014-03-11 CN CN201480015753.8A patent/CN105072928B/zh active Active
- 2014-03-11 ES ES14717284T patent/ES2736313T3/es active Active
- 2014-03-11 BR BR112015018335A patent/BR112015018335A2/pt not_active IP Right Cessation
- 2014-03-11 SG SG11201505689PA patent/SG11201505689PA/en unknown
- 2014-03-11 RU RU2015140269A patent/RU2015140269A/ru not_active Application Discontinuation
- 2014-03-14 AR ARP140101035A patent/AR095332A1/es unknown
- 2014-03-14 TW TW103109602A patent/TW201521603A/zh unknown
- 2014-10-14 US US14/513,584 patent/US9457058B2/en active Active
-
2015
- 2015-09-11 PH PH12015502071A patent/PH12015502071A1/en unknown
-
2016
- 2016-05-03 HK HK16104998.6A patent/HK1216976A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2736313T3 (es) | 2019-12-27 |
US20150093463A1 (en) | 2015-04-02 |
AU2014237014A1 (en) | 2015-08-13 |
US9457058B2 (en) | 2016-10-04 |
BR112015018335A2 (pt) | 2017-08-22 |
HK1216976A1 (zh) | 2016-12-16 |
TW201521603A (zh) | 2015-06-16 |
CN105072928A (zh) | 2015-11-18 |
US20140271553A1 (en) | 2014-09-18 |
EP2983531A1 (en) | 2016-02-17 |
MX365415B (es) | 2019-06-03 |
PH12015502071B1 (en) | 2016-01-25 |
MY172218A (en) | 2019-11-18 |
RU2015140269A (ru) | 2017-04-21 |
MX2015011934A (es) | 2015-12-01 |
PH12015502071A1 (en) | 2016-01-25 |
US8889633B2 (en) | 2014-11-18 |
EP2983531B1 (en) | 2019-04-24 |
NZ710020A (en) | 2020-04-24 |
CA2905799A1 (en) | 2014-09-25 |
WO2014150558A1 (en) | 2014-09-25 |
CN105072928B (zh) | 2021-02-12 |
PE20151978A1 (es) | 2016-01-23 |
CA2905799C (en) | 2021-03-30 |
AU2014237014B2 (en) | 2018-02-22 |
SG11201505689PA (en) | 2015-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR095332A1 (es) | Composiciones nutricionales que contienen un componente peptídico con propiedades anti-inflamatorias y método para reducir una respuesta inflamatoria | |
CR20150476A (es) | Oxopyridine derivados sustituidos y su uso en el tratamiento de trastornos cardiovasculares | |
CR20160222U (es) | Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas | |
CL2017001632A1 (es) | Manufactura de proteína. | |
BR112015023184A2 (pt) | método para o tratamento de uma doença, inibidor e seu uso, composição, método de identificação de um composto e método para inibir a produção de il-4, il-5 e il-13 | |
PE20181176A1 (es) | Composiciones biofarmaceuticas | |
CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
ECSP15043422A (es) | Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina | |
DOP2016000006A (es) | Bencil-1h-pirazolo[3,4-b]piridinas y su uso | |
PE20151947A1 (es) | Reduccion de la respuesta proinflamatoria | |
CO2018002438A2 (es) | Composiciones de micropartículas que comprenden saflufenacil | |
AR089960A1 (es) | Compuesto de imidazolopiridina para el tratamiento de enfermedades degenerativas e inflamatorias | |
WO2014199322A3 (en) | Wear resistant compositions with low particulate contamination and method of making those compositions | |
BR112017001966A2 (pt) | ?método para produzir variantes com um fc com sialilação melhorada? | |
BR112017010804A2 (pt) | polímero em multi-estágio, sua composição, seu método de preparação, seu uso e composição compreendendo o mesmo | |
PE20141826A1 (es) | Uso de composiciones nutricionales que incluyen lactoferrina en apoyo a la resistencia a enfermedades y condiciones | |
PE20151999A1 (es) | Composiciones nutricionales que contienen un componente peptidico y usos del mismo | |
CO2019005851A2 (es) | Optimización de fabricación de gl-2045, un stradomer multimerizante | |
CO2019011227A2 (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
AR095661A1 (es) | Método de activación de adiponectina mediante hidrolizado de caseína | |
UY34267A (es) | Métodos para aumentar el contenido de proteínas,aceites y/o aminoácidos en una planta | |
PH12018502207A1 (en) | Methods of manufacturing nutritional formulations | |
BR112017006803A2 (pt) | formulações bioterapêuticas tópicas de cereja ácida, método de fabricação e método de tratamento de sintomas de osteoartrite humana | |
UY34266A (es) | Métodos para aumentar el contenido de proteínas,aceites y/o aminoácidos en una planta | |
MX2015010163A (es) | Bionanoparticulas biodegradables para liberacion del peptido gse24-2, procedimiento de obtencion y utilizacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |